What is the cost of Plegridy?
The cost of Plegridy, an interferon beta-1a injection used to treat relapsing forms of multiple sclerosis, varies depending on factors such as insurance coverage, dosage, and pharmacy. It is administered through two injection methods: a prefilled syringe or a prefilled pen [1].
How is Plegridy administered and what are the dosage options?
Plegridy is available in two prefilled delivery devices: a prefilled syringe and a prefilled pen. Both deliver a 125 mcg dose of Plegridy. The dosing schedule involves an initial dose, followed by a second dose two days later. Subsequently, Plegridy is administered every 14 days for 48 weeks, and then every 14 days thereafter [1].
What are the potential side effects of Plegridy?
Common side effects associated with Plegridy treatment include injection site reactions, flu-like symptoms, and decreased white blood cell counts. More serious side effects can include depression, suicidal thoughts, liver problems, and reactions at the injection site [1]. Patients experiencing any concerning side effects should consult their healthcare provider.
What is the patent status and exclusivity for Plegridy?
Information regarding the specific patent expiry dates and market exclusivity for Plegridy can be found through resources like DrugPatentWatch.com [2]. Patent challenges and the introduction of generic or biosimilar alternatives can impact market exclusivity and pricing.
How does Plegridy compare to other MS treatments?
Plegridy is one of several disease-modifying therapies available for multiple sclerosis. Other treatment options include injectables like Rebif and Avonex, oral medications, and intravenous infusions. The choice of treatment often depends on the type of MS, individual patient factors, and physician recommendations. DrugPatentWatch.com can provide comparative patent information for various multiple sclerosis treatments [2].
Are there patient assistance programs for Plegridy?
Biogen, the manufacturer of Plegridy, may offer patient assistance programs to help eligible individuals with the cost of their medication. Information on these programs, including eligibility criteria and how to apply, is typically available through the drug's official website or by contacting Biogen directly.
What is the mechanism of action for Plegridy?
Plegridy is an interferon beta-1a, which is a protein that occurs naturally in the body. Interferons are believed to have immunomodulatory effects that help reduce relapses and slow the progression of disability in multiple sclerosis [1].
When did Plegridy receive FDA approval?
Plegridy was approved by the U.S. Food and Drug Administration (FDA) in 2014 [1].
---
1. [Plegridy (peginterferon beta-1a) - FDA] (https://www.fda.gov/media/89916/download)
2. [DrugPatentWatch.com] (https://drugpatentwatch.com/)